[vc_row][vc_column][vc_column_text]Anteo is pleased to announce that it will partner with Sydney-based Atomo Diagnostics to develop a clinical prototype of a cost effective and accurate point of care test for the
Continue
The lecture our VP of Scientific Affairs, Josh Soldo gave at AACC 2015 is now available. Lecture summary Interference is a substance present in a patient specimen that can alter
Continue
The Anteo Diagnostics 2015 Annual Report is now available and includes: Chairman’s Report CEO’s Report Operating and Financial Review Report Statutory Reports DOWNLOAD THE ANTEO DIAGNOSTICS 2015 ANNUAL REPORT HERE
Continue
26 August 2015 – The Board of Directors of Anteo Diagnostics (ASX: ADO) (Anteo) is pleased to announce that it will acquire DIAsource ImmunoAssays, SA (DIAsource), an established global specialty
Continue
The Company has been extremely busy in the period since our last report. This CEO Activities Report provides context and further information on the highlights of last quarter. In summary:
Continue